UNICREDIT BANK GMBH | Delayed Deutsche Boerse AG 03:54:56 2024-07-01 EDT | ||
| 87.04 USD | -0.10% |
|
| Current month | -1.90% | ||
| 1 month | -1.36% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-07-01 | 87.04 | -0.10% |
| 24-06-28 | 87.13 | +0.82% |
| 24-06-27 | 86.42 | +1.17% |
| 24-06-26 | 85.42 | -2.53% |
| 24-06-25 | 87.64 | +0.38% |
Delayed Quote Deutsche Boerse AG
Last update July 01, 2024 at 03:54 am
More quotesStatic data
| Product type | Obligations Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
UniCredit
|
| WKN | HC83QA |
| ISIN | DE000HC83QA8 |
| Date issued | 2023-07-21 |
| Strike | 32.31 $ |
| Maturity | 2024-07-15 (15 Days) |
| Parity | 0.03 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | les deux |
| Currency | USD |
Technical Indicators
| Highest since issue | 101.8 $ |
|---|---|
| Lowest since issue | 79.3 $ |
| Spread | 1.2 $ |
| Spread % | 0.14% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.98
USD
Average target price
31.92
USD
Spread / Average Target
+14.07%
- Stock Market
- Certificates
- Certificat
